Abstract:The development of various chemical methods has enabled scientists to decipher the distribution features and biological functions of RNA modifications in the past decade. In addition to modifying noncoding RNAs such as tRNAs and rRNAs, N6-methyladenosine (m6A) has been proven to be the most abundant internal chemical modification on mRNAs in eukaryotic cells and is also the most widely studied mRNA modification to date. Extensive studies have repeatedly demonstrated the important functions of m6A in various biological conditions, ranging from embryonic organ development to adult organ function and pathogenesis. Unlike DNA methylation which is relatively stable, the reversible m6A modification on mRNA is highly dynamic and easily influenced by various internal or external factors, such as cell type, developmental stage, nutrient supply, circadian rhythm, and environmental stresses.In this Account, we review our previous findings on the site selectivity mechanisms regulating m6A formation, as well as the physiological roles of m6A modification in cerebellum development and long-term memory consolidation. In our initial efforts to profile m6A in various types of mouse and human cells, we surprisingly found that the sequence motifs surrounding m6A sites were often complementary with the seed sequences of miRNAs. By manipulating the abundance of the miRNA biogenesis enzyme Dicer or individual miRNAs or mutating miRNA sequences, we were able to reveal a new role of nucleus localized miRNAs, which is to guide the m6A methyltransferase METTL3 to bind to mRNAs and to promote m6A formation. As a result, we partially answered the question of why only a small proportion of m6A motifs within an mRNA could have m6A modification at a certain time point. We further explored the functions of m6A modification in regulating brain development and brain functions. We found that cerebellum had the most severe defects when Mettl3 was knocked out in developing mouse embryonic brain and revealed that the underlying mechanisms could be attributed to aberrant mRNA splicing and enhanced cell apoptosis under m6A deficit conditions. On the other hand, knocking out Mettl3 in postnatal hippocampus did not cause morphological defects in the mouse brain but impaired the efficacy of long-term memory consolidation. Under learning stimuli, formation of m6A modifications could be detected on transcripts encoding proteins related to dendrite growth, synapse formation, and other memory related functions. Loss of m6A modifications on these transcripts would result in translation deficiency and reduced protein production, particularly in the translation of early response genes, and therefore would compromise the efficacy of long-term memory consolidation. Interestingly, excessive training sessions or increased training intensity could overcome such m6A deficiency related memory defects, which is likely due to the longer turnover cycle and the cumulative abundance of proteins throughout the training process. In addition to revealing the roles of m6A modification in regulating long-term memory formation, our work also demonstrated an effective method for studying memory formation efficacy. As the lack of an appropriate model for studying memory formation efficacy has been a long-lasting problem in the field of neural science, our hippocampus-specific postnatal m6A knockout model could also be utilized to study other questions related to memory formation efficacy.

Knockdown of METTL16 Disrupts Learning and Memory by Reducing the Stability of MAT2A Mrna

METTL3-mediated N6-methyladenosine mRNA modification enhances long-term memory consolidation

N6-methyladenosine participates in mouse hippocampus neurodegeneration via PD-1/PD-L1 pathway

N6-Methyladenosine mRNA Modification: From Modification Site Selectivity to Neurological Functions

METTL5, an 18S Rrna-Specific M6a Methyltransferase, Modulates Expression of Stress Response Genes

N6-methyladenosine RNA modification of glutamatergic neurons is associated with contextual fear discrimination

M6a Regulates Neurogenesis and Neuronal Development by Modulating Histone Methyltransferase Ezh2

M6a Facilitates Hippocampus-Dependent Learning and Memory Through YTHDF1.

METTL3 confers protection against mitochondrial dysfunction and cognitive impairment in an Alzheimer disease mouse model by upregulating Mfn2 via N6-methyladenosine modification

Mettl5 mediated 18S rRNA N6-methyladenosine (m6A) modification controls stem cell fate determination and neural function

Loss of the M6a Methyltransferase METTL3 in Monocyte-Derived Macrophages Ameliorates Alzheimer’s Disease Pathology in Mice

M(6)A Deposition Is Regulated By Prmt1-Mediated Arginine Methylation Of Mettl14 In Its Disordered C-Terminal Region

The U6 Snrna M6a Methyltransferase METTL16 Regulates SAM Synthetase Intron Retention

Arginine Methylation of METTL14 Promotes RNA N6-methyladenosine Modification and Endoderm Differentiation of Mouse Embryonic Stem Cells.

Mettl3‐mediated m6A modification of Lrp2 facilitates neurogenesis through Ythdc2 and elicits antidepressant‐like effects

METTL16 exerts an m6A-independent function to facilitate translation and tumorigenesis

METTL16 drives leukemogenesis and leukemia stem cell self-renewal by reprogramming BCAA metabolism

SUMOylation of the M6a-Rna Methyltransferase METTL3 Modulates Its Function.

Altered N6-Methyladenosine Modification Patterns and Transcript Profiles Contributes to Cognitive Dysfunction in High-Fat Induced Diabetic Mice

Decreased expression of Chrna4 by METTL3-mediated m6A modification participates in BPA-induced spatial memory deficit

METTL3-Dependent N6-Methyladenosine Modification Programs Human Neural Progenitor Cell Proliferation